Imara to Present Clinical Data on IMR-687 as Monotherapy and in Combination with Hydroxyurea in Patients with Sickle Cell Disease at the 62nd ASH Annual Meeting and Exposition
30th November 2020
Portfolio
This post references, or is about Imara. Find out more by clicking below
Print Article
Email Article
Save Article
Stay Updated
Add your email below to stay updated with useful and informative content from Arix and our portfolio companies
